Type: Conjugate
₹3975
Incl. 5% GST
NUKOVAX 13 is a pneumococcal conjugate vaccine developed in China, procured by G.C. Chemie Pharmie Ltd, and remarketed by Lupin. It provides comprehensive protection against 13 strains of Streptococcus pneumoniae, the bacteria responsible for severe infections like pneumonia, meningitis, and sepsis. The vaccine uses tetanus toxoid (TT) as a carrier protein to enhance immune response, making it highly effective, especially for children.
Requires 4 doses
